Shanshan Li | Skin Wound Healing | Excellence in Research Award

Published on by Cognitive Scientist Awards

Dr. Shanshan Li | Skin Wound Healing | Excellence in Research Award

Xuzhou Medical University, Department of Forensic Medicine | China

Dr. Shanshan Li is an associate professor and deputy chief forensic physician at Xuzhou Medical University, recognized for her strong academic foundation in forensic medicine and her contributions to wound healing and neurotrauma research. She completed her clinical and forensic medical training across leading Chinese institutions and enhanced her expertise through postdoctoral clinical research and international academic exposure as a visiting scholar. Her professional experience spans teaching, pathology practice, forensic consultation, and mentorship of diverse student groups, supported by an active role on youth editorial boards in reputable medical journals. Her research interests focus on skin wound repair, the wound microenvironment, and brain contusion, and she has developed skills in transcriptomic analysis, molecular pathology, nanoparticle therapeutics, fibrosis regulation, and experimental design. Her scholarly output includes numerous high-impact publications as a first or corresponding author, patents as a primary inventor, and a co-authored academic book, reflecting her innovative contributions to forensic and biomedical science. She is an active member of regional forensic associations and has earned recognition through competitive research projects and editorial appointments. Overall, Dr. Li’s work advances understanding of tissue regeneration and neuroinflammation, demonstrating her commitment to scientific excellence and strengthening her candidacy for recognition in research distinction.

Profile: ORCID

Featured Publications

Zhou, Z., Huang, X., Chen, C., Zou, T., Hai, Y., Dong, G., & Li, S. (2026). LncRNA RMST knockout inhibits fibrosis by down-regulating Smad3 during mouse skin wound healing. Biochemistry and Biophysics Reports, 45, 102386.

Zhao, T., Zhou, Y., Zhang, D., Han, D., Ma, J., Li, S., Li, T., Hu, S., & Li, Z. (2024). Inhibition of TREM-1 alleviates neuroinflammation by modulating microglial polarization via SYK/p38MAPK signaling pathway after traumatic brain injury. Brain Research, 1834, 148907.

Zhang, X., Huang, X., Hang, D., Jin, J., Li, S., Zhu, Y., & Liu, H. (2024). Targeting pyroptosis with nanoparticles to alleviate neuroinflammatory for preventing secondary damage following traumatic brain injury. Science Advances, 10(2), eadj4260.

Elif Baris | Pharmacology | Excellence in Research Award

Published on by Cognitive Scientist Awards

Assoc. Prof. Dr. Elif Baris | Pharmacology | Excellence in Research Award

İzmir University of Economics | Turkey

Elif Baris is an Assistant Professor of Medical Pharmacology at Izmir University of Economics, specializing in molecular pharmacology with a strong focus on inflammation, pain physiology, and cholinergic anti-inflammatory mechanisms. She holds a pharmacy degree and a doctoral qualification in medical pharmacology from Dokuz Eylül University, and has developed expertise in cytokine signaling, oxidative stress, neuroimmune modulation, molecular oncology, stem cell immunoregulation, and sepsis models. Her professional experience includes leading and contributing to numerous multidisciplinary research projects supported by national and institutional scientific bodies, alongside collaborations with prominent medical and biotechnology institutions. Her research interests extend to autonomic nervous system pharmacology, neuroimmune interactions, mechanotransduction through TRPV4 channels, and innovative drug repurposing strategies. She possesses strong research skills in qRT-PCR, Western blotting, ELISA, cytokine arrays, flow cytometry, and real-time cell analysis, supported by extensive publications in indexed journals and multiple patents involving varenicline- and choline-based therapeutic applications. She has received recognition through collaborative roles in funded research, chapter authorship in academic publications, and contributions to translational pharmacology. Her professional memberships include national societies in pharmacology and physiology, reflecting her commitment to scientific advancement. With her growing contributions to drug innovation, inflammation therapeutics, and molecular pharmacology, she continues to advance impactful research aimed at improving mechanisms of pain management and immune regulation.

Profile: Google scholar

Featured Publications

Baris, E., Efe, H., Gumustekin, M., Arici, M. A., & Tosun, M. (2021). Varenicline prevents LPS-induced inflammatory response via nicotinic acetylcholine receptors in RAW 264.7 macrophages. Frontiers in Molecular Biosciences, 8, 721533. [15 citations]

Baris, E., Simsek, O., Arici, M. A., & Tosun, M. (2023). Choline and citicoline ameliorate oxidative stress in acute kidney injury in rats. Bratislava Medical Journal / Bratislavské Lekárske Listy, 124(1). [12 citations]

Baris, E., Simsek, O., Efe, H., Oncu, S., Gelal, A., Hamurtekin, E., Tosun, M., … (2021). Effects of CDP-choline and choline on COX pathway in LPS-induced inflammatory response in rats. International Journal of Pharmacology, 17(2), 84–96. [10 citations]

Baris, E., Arici, M. A., & Tosun, M. (2024). Nicotinic acetylcholine receptor-mediated effects of varenicline on LPS-elevated prostaglandin and cyclooxygenase levels in RAW 264.7 macrophages. Frontiers in Molecular Biosciences, 11, 1392689. [4 citations]

 

Henry Nelson Puerta-Guardo | Microbe-Host Biology and Vector Control | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Henry Nelson Puerta-Guardo | Microbe-Host Biology and Vector Control | Best Researcher Award

Universidad Autonoma de Yucatan | Mexico

Dr. Henry Puerta-Guardo is an accomplished Associate Research Professor at the Universidad Autónoma de Yucatán (UADY), Mexico, recognized for his extensive contributions to virology, viral pathogenesis, and vector-borne disease research. He completed his academic training in bacteriology at the University of San Buenaventura, followed by a master’s degree in microbiology and cellular biology from the Venezuelan Institute for Scientific Research, a PhD in infectomics and molecular pathogenesis from CINVESTAV, and postdoctoral research in viral pathogenesis at the University of California, Berkeley. His professional career spans research, teaching, and editorial roles in leading institutions and journals, where he explores the molecular mechanisms of dengue and Zika viruses, host-pathogen interactions, and vector control strategies. His primary research interests include endothelial barrier dysfunction, immune response to flavivirus infections, molecular virology, and epidemiology of arboviruses. Dr. Puerta-Guardo is skilled in cellular and molecular biology, vascular-endothelial biology, and diagnostics development. His numerous awards, such as the National Laboratory for Genomics in Biodiversity Award, the Wellcome Trust Award, and recognition from the National System for Researchers, highlight his scientific excellence. Through innovative interdisciplinary collaborations, he continues to advance global understanding of emerging infectious diseases and develop preventive strategies against arbovirus transmission in endemic regions.

Profile: Google scholar

Featured Publications